Aims-To compare the application of a non-radioactive in situ hybridisation (ISH) technique with an immunocytochemical technique for the detection of human parvovirus B19 in formalin fixed, paraffin wax embedded sections ofmacerated fetal tissue. Methods-Archived samples of liver, lung or kidney from 19 human fetuses were investigated for parvovirus B19 using a full length digoxigenin labelled DNA probe of 5.5 kb; bound probe was detected using an anti-digoxigenin (alkaline phosphatase) conjugate and visualised using NBT/BCIP. Immunocytochemical detection of parvovirus B19 was performed using a monoclonal mouse antiparvovirus B19 antiserum, with a streptavidin-biotin complex (horse radish peroxidase) method. Previous studies have shown parvovirus B 19 to be associated with many pathological conditions,"6 including aplastic crises associated with sickle cell anaemia, acute arthritis and arthralgia, and erythema infectiosum. Parvovirus B 19 has also been shown to cross the placenta and infect the fetus causing stillbirths,7 8 spontaneous miscarriage, and congenital abnormalities, although there is evidence to suggest that fetal infection with the virus is not always fatal.8 It has also been implicated in the development of non-immune hydrops fetalis9 where the risk offetal death was estimated at 9% in a study of women who had parvovirus B19 positive serology during their pregnancy."'
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Aims-To compare the application of a non-radioactive in situ hybridisation (ISH) technique with an immunocytochemical technique for the detection of human parvovirus B19 in formalin fixed, paraffin wax embedded sections ofmacerated fetal tissue. Methods-Archived samples of liver, lung or kidney from 19 human fetuses were investigated for parvovirus B19 using a full length digoxigenin labelled DNA probe of 5.5 kb; bound probe was detected using an anti-digoxigenin (alkaline phosphatase) conjugate and visualised using NBT/BCIP. Immunocytochemical detection of parvovirus B19 was performed using a monoclonal mouse antiparvovirus B19 antiserum, with a streptavidin-biotin complex (horse radish peroxidase) method. Cases were selected to provide a range of diagnostic certainty and a range of degrees of macerative degeneration. Results group.bmj.com on July 6, 2017 -Published by http://jcp.bmj.com/ Downloaded from the authors to suggest that the incidence of infection may be more common than is generally thought. 9 All four of the definite positives for viral inclusion bodies on the haematoxylin and eosin stained sections were positive with ISH, but only three of four were positive by immunocytochemistry. Only one case (8) with dubious eosinophilic inclusions turned out to be negative by both ISH and immunocytochemistry. None of the remaining 11 ISH positive cases showed definite viral inclusions in the tissues tested but four cases showed inclusions when haematoxylin and eosin stained sections of other tissue samples were examined retrospectively (table 1) . Only two cases showed excellent immunocytochemical staining with a further three showing acceptable or weak staining.
An ISH signal was seen in six of seven of the severely macerated cases compared with three of seven using immunocytochemical staining; with the exception of one case (11), the immunocytochemical staining was inferior to that seen with the ISH. These findings suggest that ISH is more effective than immunocytochemistry at detecting parvovirus B 19 in macerated tissues, in agreement with the study of Morey et al. 21 In the latter study, there was no significant difference in the detection rate between ISH and immunochemistry in optimally preserved tissues; however, an association between decreased immunochemical sensitivity and macerated tissues was observed.
The improved detection rate with ISH may in part result from a much clearer signal seen against virtually no background staining. In comparison, the immunocytochemically stained sections, especially in macerated liver, showed a serious increase in background staining. This is possibly due to binding of the avidin-biotin complex (used for detection) to endogenous biotin, or cross reactivity of the antisera with protein moieties.22 The negative control sections also showed background staining. Blocking of endogenous biotin may improve staining quality, but it is unlikely that the positive detection rate would rise significantly as the degree of cellular disruption in macerated tissue precludes identification of the precise intracellular location of the positively stained material.
The method of detection for parvovirus B 19 is dependent on the timing of the diagnosis. Clinically recent infections can be detected using serology,23 while for macerated postmortem tissues, the choices of detection are narrowed. More sensitive assays rely on detection using dot blot or polymerase chain reaction (PCR) techniques but these may produce false positive results with fixed tissues, which are likely to be examined in a histopathology department. Reliable extraction methods require optimisation, and PCR equipment is not always available. In a recent study of six parvovirus B19 positive fetuses using PCR, five cases were positive by immunochemistry and ISH."4 However, the in situ and immunochemistry techniques were negative on a different case suggesting the need for caution if using only one of these techniques. The B 19 genome is rich in cytosine-guanosine content, conferring good nuclear stability due to strong secondary structure'0; this probably endows the genome with its resistance to degradation in macerated fetal tissues whereas the B19 protein coat seems be more susceptible.
In this study, we have shown ISH to be more sensitive than immunocytochemistry for the detection of parvovirus B 19 in fixed, paraffin processed blocks of macerated fetal tissue. Although liver usually shows more advanced maceration than other tissues, excellent staining was achieved with ISH suggesting the parvovirus B 19 genome is resistant to the effects of tissue maceration. The use of less susceptible tissue also gave good results. We therefore recommend ISH for the detection of parvovirus infection in macerated fetal tissue.
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